Short answer
HERON THERAPEUTICS, INC. /DE/ (HRTX) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All seven director nominees elected, with support ranging from 85,276,872 to 88,537,725 votes.
HERON THERAPEUTICS, INC. /DE/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All seven director nominees elected, with support ranging from 85,276,872 to 88,537,725 votes
- Equity plan expanded by 16,560,000 shares, increasing potential dilution and employee compensation capacity
- Employee stock purchase plan expanded by 10,000,000 shares, adding further possible dilution
- Executive compensation approved 77,315,474 to 12,117,861 on an advisory basis
- Withum Smith+Brown ratified as 2026 independent auditor; Tax Benefits Preservation Plan ratified 88,182,895 to 3,442,815
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HERON THERAPEUTICS, INC. /DE/ 8-K filings
Get the next HRTX 8-K as it lands
Follow HRTX for push alerts, or ask the research agent what this filing means.